Understanding how and why an otherwise tumor-restrictive stroma evolves into a tumor-permissive stroma. We believe that therapies restoring the tumor restrictive stroma by normalizing extracellular matrix turnover are the future of clinical cancer research.
The hallmark of a tumor-permissive stroma is a disruption of tissue microarchitecture and altered extracellular matrix (ECM) remodeling. The extracellular matrix alterations in the tumor fuel a vicious cycle of stromal dissemination enriching for cancer-associated fibroblast (CAFs), desmoplasia, immunosuppression and an epithelial-to-mesenchymal transition leading to poor efficacy of interventions.
A patient-centric approach to evaluate extracellular matrix biomarkers in clinical trials with the potential to predict the likelihood of response and elaborate on method-of-action by monitoring direct or "bystander" effect on the extracellular matrix. In contrast to most other liquid biopsies that focus on circulating tumor DNA (ctDNA) or circulating tumor cells (CSCs), at Nordic Bioscience we focus our biomarker efforts on targeting and quantifying post-translational modifications (PTMs) on proteins or peptide fragments in circulation.
Nordic ProteinFingerPrint Technology™ allows for a tumor agnostic approach (solid tumors) to address tumor microenvironment alterations that can be tracked to specific cellular and biological processes through non-invasive quantification of extracellular matrix turnover and with clear value for drug development and benefit for patients.
Clear value | |
Tumor fibrosis | Predict response |
Fibroblast (CAF) activity | Monitor tissue changes |
Invasion Metastasis | Pharmacodynamics |
Pre-metastatic niche | Mode-of-action |
Angiogenesis | Efficacy |
Tissue stiffness | Prognosis |
Proteolytic activity | Endotyping |
Inflammation and | Stratification |
Visit our cancer biomarker portfolio and choose a panel that fits your clinical research or drug development targets!
The applications presented here are for research use only.
Search and find publications that we have published.
Please don't hesitate to contact us if you have any questions or other inquiries.
